Drug Pipeline

Enlonstobart injection Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
1
Recruiting
2
Phase 3
2
Top Sponsors
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-06-08 NCT07633873 SYS6010 Combined With Enlonstobart Versus Immunotherapy+ Platinum-based Chemotherapy for… Phase 3 Not Yet Recruiting
2026-06-03 NCT07622225 SYS6006 in Combination With Enlonstobart Injection Versus Enlonstobart Injection in… Phase 1/2 Not Yet Recruiting
Active Studies by Phase
Phase 3
1
Phase 2/3
1
Phase 2
1
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07633873 SYS6010 Combined With Enlonstobart Versus Immunotherapy+ Platinum-based Chemotherapy for… Non-Small Cell Lung Cancer Not Yet Recruiting
Phase 2/3
NCT07332533 A Study of KN026-based Combination Therapy in HER2-positive Gastric Cancer HER2-positive Gastric Cancer Not Yet Recruiting
Phase 2
NCT07254585 SYS6010 Combined With Enlonstobart In Recurrent Or Metastatic Head And Neck Squamous Cell… Head and Neck Squamous Cell Carcinoma Recruiting
Phase 1/2
NCT07622225 SYS6006 in Combination With Enlonstobart Injection Versus Enlonstobart Injection in… Advanced Solid Tumors Not Yet Recruiting
Sponsors Running Enlonstobart injection Trials
CSPC Megalith Biopharmaceutical Co.,Ltd. (3) Shanghai JMT-Bio Inc. (1)
Disease Areas
Head & Neck Cancer (1) Gastric Cancer (1) Non-Small Cell Lung Cancer (NSCLC) (1) Lung Cancer (1)
Get alerts when Enlonstobart injection trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free